Evaluating Transdermals Medication Froms for Veterinary Patients, Part 2

Author(s):  Davidson Gigi S

Issue:  May/Jun 2001 - The Business of Compounding
View All Articles in Issue

Abstract:  In this article, the author provides information regarding drugs and drug classes (cyclophyosphamide, chloramphenicol and potassium salts) that she believes should never be administered transdermally. She concludes that it is necessary to consider the risk of causing toxicity via transdermal administration. The drugs listed in this article represent types of potentially dangerous drugs that may be suggested for topical application. To produce the most positive veterinary therapeutic outcomes, the pharmacist and veterinarian must constantly reevaluate the benefit-risk ratio for both the patient and caregiver before drugs are administered transdermally.

Related Categories: VETERINARY

Purchase this article for download in electronic PDF format from IJPC at for $75 at:
https://ijpc.com/Abstracts/Abstract.cfm?ABS=1010

Search the entire IJPC archive by keyword, topic, or issue at:
https://ijpc.com/Products